This screening assay is used to determine the bioavailability/exposure of test compounds after two routes of administration to male mice.
Required from Customer
- Test compound in powder form or preformulated
- Dose routes – any two routes, including intravenous (IV), oral gavage (OG), subcutaneous (SC), and intraperitoneal (IP)
- Dose (mg/kg) of test compound
- Molecular mass (exact mass) of each test compound and its salt form
- MSDS or handling and storage information,
e.g., light sensitive, store at -20°C, stability, etc.
- If applicable, instructions for dosing vehicle preparation
- In-life observations on each mouse
- A table containing test compound concentrations in blood samples at each time point
- A table listing relative exposure (bioavailability) based on AUC for each compound and Concentration vs. Time profiles
- A table containing appropriate pharmacokinetic parameters for each dose route: Cmax and Tmax for each compound, and half-life, clearance, and volume of distribution of each compound after IV administration, if applicable
- Test compound in an appropriate dosing vehicle either individually or as a pool of compounds (cassette dose)
- Conscious, fasted, male CD-1 mice weighing between 20 and 40 grams; water is offered ad libitum
- Dose three mice (N=3) per dose route
- Sample blood (typically from the tail vein) at the following time points:
- 5 (IV), 15, 30 min, 1, 3, and 6 hours
- Predose (0) blood samples are taken from satellite mice from the same cohort as the study animals
- Mix blood with an equal volume of water and freeze
- Determine the concentrations of test compound in dosing solution and incurred samples using a generic LC-MS/MS method with a minimum 8 point calibration curve
- For cassette dosing, one analytical method will be developed to include all compounds (if feasible) and one single injection will be used to quantify all test compounds
- Non-compartmental analysis is used to determine PK parameters for each test compound
- 5/8 of the calibration standards must be within ±20% of the theoretical values to accept the analytical run
- The results from this study are provided to the customer in the ExpressPlus report format, which may include graphical representations of data and comparison with historical data for reference compounds.
- The analytical rigor does not include a pre-study validation, and QCs will not be used for sample analysis.
- Cassette dosing is a rapid and lower cost method for screening the pharmacokinetics of drug discovery candidates. However, interpretation of cassette dosing results can be confounded by drug-drug interactions among the drug candidates.
- Mass of each test compound must differ by at least 5 amu if cassette dosed—up to 5 compounds can be dosed in a single cassette—whether this is effective depends upon the compounds.
- Price for cassette dosing is for one analytical method and one single injection for quantification of all analytes.
- The blood from mice dosed with different test compounds is pooled for analysis—whether this is effective depends upon the compounds.
- If required, Absorption Systems can determine a suitable dosing vehicle and prepare it for the experiment. Alternatively, Absorption Systems can prepare the dosing vehicle if the customer provides instructions.
- One hour formulation prep cost has been included in the study price. Additional time required for formulation preparation will be charged.
- Dose vehicle development is not included as part of this assay.
- The standard anticoagulant is sodium heparin. Additional fees may apply if an alternate anticoagulant is requested.
- The customer must specify:
• any two dose routes – IV, OG, IP, or SC
• individual vs. cassette dosing
• the dose (mg/kg) of each dose route
• the formulation instructions, if applicable
- The customer can request:
• the number of replicates (typically 3)
• different time points and an extended duration
• that Absorption Systems determine a suitable dosing vehicle
• that Absorption Systems prepare the dosing vehicle using the customer’s instructions
• that plasma is analyzed instead of hemolyzed blood—whether this is effective depends upon the compounds.
1 thought on “Mouse PK”
I am a consultant and my client needs some idea of ‘quick and dirty’ costs so they can fund raise off proof of concept.